Note: Ingredients listed on restricted chemical lists
EC/CAS
233-245-9/10099-74-8
Name of the chemical
Lead dinitrate
Concentration
>=3-<10
General Information
Version
8.7
Revision date
2025-03-12
Product name
LEAD STANDARD 1000 MG PB, (PB(NO3)2 IN H2O) TITRISOL
1.2.1 Relevant identified uses
Reagent for analysis
1.2.2. Uses advised against
For R&D use only. Not for pharmaceutical, household or other uses
Icons in SDS
Company Information
company name
Merck Pty Ltd
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H317, H318, H351, H360Df, H373, H400, H410, H411
Hazard statements
Code
Statements
H317
May cause an allergic skin reaction
H318
Causes serious eye damage.
H351
Suspected of causing cancer
H360Df
May damage the unborn child. Suspected of damaging fertility.
H373
May cause damage to organs through prolonged or repeated exposure
H400
Very toxic to aquatic life
H410
Very toxic to aquatic life with long lasting effects
H411
Toxic to aquatic life with long lasting effects
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
Serious eye damage, (Category H318 Causes serious eye damage 1) Skin sensitization, (Category 1) H317 May cause an allergic skin reaction. Carcinogenicity, (Category 2) H351 Suspected of causing cancer. Reproductive toxicity, (Category H360Df May damage the unborn child. 1A) Suspected of damaging fertility. Specific target organ toxicity - H373: May cause damage to organs repeated exposure, (Category 2), through prolonged or repeated exposure. Blood, Central nervous system, Immune system, Kidney Short-term (acute) aquatic H400: Very toxic to aquatic life. hazard, (Category 1) Long-term (chronic) aquatic H411: Toxic to aquatic life with long lasting hazard, (Category 2) effects.
2.2 Label elements
Labelling
Signal word
Danger Danger
Hazard statements
H317 May cause an allergic skin reaction. H318 Causes serious eye damage. H351 Suspected of causing cancer. H360Df May damage the unborn child. Suspected of damaging fertility. H373 May cause damage to organs (Blood, Central nervous system, Immune system, Kidney) through prolonged or repeated exposure. H410 Very toxic to aquatic life with long lasting effects. Restricted to professional users. Reduced Labeling (<= 125 ml) H317 May cause an allergic skin reaction. H351 Suspected of causing cancer. H318 Causes serious eye damage. H360Df May damage the unborn child. Suspected of damaging fertility.
Precautionary statements
P202 Do not handle until all safety precautions have been read and understood. P273 Avoid release to the environment. P280 Wear protective gloves/ protective clothing/ eye protection/ face protection. P302 + P352 IF ON SKIN: Wash with plenty of water. P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P308 + P313 IF exposed or concerned: Get medical advice/ attention. P202 Do not handle until all safety precautions have been read and understood. P280 Wear protective gloves/ protective clothing/ eye protection/ face protection. P302 + P352 IF ON SKIN: Wash with plenty of water. P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P308 + P313 IF exposed or concerned: Get medical advice/ attention.
Supplemental label elements
none none
2.3 Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.
ECOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
TOXICOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.